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Abstract
Dioxins are persistent organic pollutants interfering with endocrine systems and causing reproductive and developmental
disorders. The objective of our project was to determine the impact of an in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) on reproductive function of male and female offspring in the rat with a special emphasis on the immature
period. We used a low dose of TCDD (unique exposure by oral gavage of 200 ng/kg at 15.5 days of gestation) in order to
mirror a response to an environmental dose of TCDD not altering fertility of the progeny. We choose a global gene
expression approach using Affymetrix microarray analysis, and testes of 5 days and ovaries of 14 days of age. Less than 1%
of the expressed genes in gonads were altered following embryonic TCDD exposure; specifically, 113 genes in ovaries and
56 in testes with 7 genes common to both sex gonads. It included the repressor of the aryl hydrocarbon receptor (Ahrr), the
chemokines Ccl5 and Cxcl4 previously shown to be regulated by dioxin in testis, Pgds2/Hpgds and 3 others uncharacterized.
To validate and extend the microarray data we realized real-time PCR on gonads at various developmental periods of
interest (from 3 to 25 days for ovaries, from 5 to the adult age for testes). Overall, our results evidenced that both sex
gonads responded differently to TCDD exposure. For example, we observed induction of the canonic battery of TCDD-
induced genes coding enzymes of the detoxifying machinery in ovaries aged of 3–14 days of age (except Cyp1a1 induced at
3–10 days) but not in testes of 5 days (except Ahrr). We also illustrated that inflammatory pathway is one pathway activated
by TCDD in gonads. Finally, we identified several new genes targeted by TCDD including Fgf13 in testis and one gene,
Ptgds2/Hpgds regulated in the two sex gonads.
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Introduction
Dioxins, which refer to a family of structurally and chemically
related polychlororinated dibenzo-p-dioxins (PCDDs) and diben-
zofurans (PCDFs) are lipophilic chemicals resistant to degradation
and categorized as persistent organic pollutants, with 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) being the most toxic dioxin.
Dioxins are suspected of interfering with the endocrine systems of
humans and wildlife [1–3] causing a broad spectrum of adverse
effects including developmental and reproductive toxicity in the
offspring of laboratory animals, and perhaps in humans. These
disorders are of very high concern, because they occur at much
lower doses than those causing wasting syndrome or carcinogen-
esis [4]. Moreover, dioxins tend to accumulate in the food chain,
essentially fatty food including breast milk, and may also cross the
placental barrier. These data emphasize that foetuses and neonates
are vulnerable populations. For example, it was recently demon-
strated that breast-fed but not formula-fed sons from mothers
exposed to dioxin after the accident in Seveso had permanently
reduced sperm quality [5]. In utero exposure to TCDD also
impaired prostate development in many mammals including rats
and mice. However, data on testicular development are debated
[6–8]. In rat females, it has also been shown that TCDD exposure
in utero is associated with malformations of external genitalia,
reduced fertility, and disruption of estrus cycles and inhibition of
ovulation [9,10].
Most of the toxic effects of TCDD are mediated through the
binding and activation of the aryl hydrocarbon receptor (AHR)
and subsequent alteration of target gene expression. The classic
battery of dioxin-responsive genes exhibit dioxin response
elements in their promoter moiety and includes phase I and
phase II enzymes of the detoxification machinery, such as the
cytochrome P450 (Cyps) 1a1 and 1b1. However, a recent study
pointed out that 65% of the gene expression responses elicited by
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TCDD do not involve direct AhR binding to a Xenobiotic
Response Element (XRE) [11]. It suggested that expression of
genes lacking a XRE element reflected indirect AhR-mediated
signalling, and that such changes in expression could be attributed
to latent secondary effects. It could as well suggest that non-
consensus XRE element may confer TCDD inducibility as shown
recently with PAI-1 [12]. These two mechanisms may well explain
the pleiotropic nature of TCDD toxicity illustrated with the large
panel of target genes identified that include for example genes
involved in cellular growth, differentiation and inflammation
[13,14].
Global gene expression technology provides a comprehensive
strategy whereby critical AHR-regulated genes apart from the
classic battery of genes can be identified, and has been used to
elucidate target pathways involved in the aetiology of TCDD and
related compounds toxicity in liver and kidney [15]. Using this
strategy, we focused our study on developing gonads, testes and
ovaries, in rats. The age of 5 days was chosen for males because
this time period coincides with germ cell reentry into mitosis, the
set-up of the spermatogonial program including stem cell self-
renewal and the maturation of the somatic cell lineages, i.e. the
Sertoli and Leydig cells [16]. Regarding females, we concentrated
on prepubertal period and specifically infantile period (from 7 to
20 days of age) when the ovary as well as the pituitary displayed an
intense endocrine activity with high levels of estradiol and
gonadotropins [17,18]. Real-time PCR was further used not only
to validate microarray data generated but also to gain more insight
into the kinetics of regulation of the identified genes along with
crucial developmental periods. In parallel, the expression level of
the classical battery of detoxifying genes was surveyed.
Overall, our results evidenced that both sex gonads responded
differently to TCDD exposure with respect to enzymes of the
detoxifying machinery. We illustrated that inflammatory pathway
is one pathway activated by TCDD in gonads. We identified
several new genes targeted by TCDD including Fgf13 in testis and
one gene, Ptgds2/Hpgds regulated in the two sex gonads.
Materials and Methods
Experimental Design
Time pregnant Sprague-Dawley females of embryonic day 12
were purchased from Janvier’s Breeding (Le Genest, France). They
were housed individually in plastic cages with food (Altromin
1310; Genestil, Royaucourt, France) and water provided ad
libitum at 23uC and a 12:12 photoperiod. Animals were randomly
assigned to treatment groups. Dams were allowed 3-day acclima-
tization and were given one oral dose of 2,3,7,8-TCDD (ref ED-
901-C) (LGC Promochem, Molsheim, France) 200 ng/kg body
weight (bw) in sesame oil on embryonic day 15. Control animals
received sesame oil. Pups were sacrificed by cervical dislocation
under CO2 anesthesia at various ages, at 3, 6, 10, 12, 14 and 25
days for females, and at 5, 28, 40, 67, 145 days for males. Ovaries
and testes were dissected and snap-frozen. Pituitaries were
collected from female pups of 3, 6, 12 and 14 days of age. In
addition, livers were collected at 5 and 28 days for males and 3 and
6 days for females. All organs were kept at 280uC before use.
Throughout the manuscript, treated organs refer to organs
collected from animals born from TCDD-exposed dams. Control
Table 1. List of primers used in the study.
List of primers Accession number Forward 5’-3’ Reverse 5’-3’ size (bp)
Ahrr NM_001024285.1 CAGCAACATGGCTTCTTTCA GAAGCACTGCATTCCAGACA 172
Cyp1a1 NM_012540.2 CAAGAGCTGCTCAGCATAGTC GCTCAATGAGGCTGTCTGTG 229
Cyp1b1 NM_012940.1 GCAGCCGCCTTCCTGGTAGC CCACGCGCCCTGTCCCTACT 116
Nqo1 NM_017000.3 TGCTTTCAGTTTTCGCCTTT GAGGCCCCTAATCTGACCTC 122
Cyp19a1 NM_017085.2 TGTTGTTGGTGACAGAGACA AAG CAAGTCCACGACAGGCTGATA 103
Star NM_031558.2 GTCATCAGAGCTGAACACGG TGGCGAACTCTATCTGGGTC 163
Art2b NM_198735.2 TGTGGTTCTCCCCAGTCTTC CTCCTTGGCCTCCCTTTAAC 104
Fgf13 NM_053428.1 TGTATCGTCAACCCCAGTCA GCCACTGTTCCACAGTTCCT 139
Gzmf NM_153466.1 CAAATGTCCGTCGATGTCAC CCCTTGTACGCAGCCTGTAT 158
Hpgds NM_031644.2 AGAGCGGACGTTCAATGACT GGTGCTGCAGATATCCCAAT 139
Hprt1 NM_012583.2 AGGACCTCTCGAAGTGT ATTCAAATCCCTGAAGTACTCAT 111
doi:10.1371/journal.pone.0040306.t001
Figure 1. TCDD-regulated genes detected by microarrays in
ovaries and testes. Genes were selected on the basis of a p-
value,0.05 and a 1.5 fold change factor of mRNA expression in
response to TCDD. The Venn diagram illustrates the repartition
between genes up- and down-regulated in testes or ovaries, and the
7 genes both regulated in testes and ovaries are listed.
doi:10.1371/journal.pone.0040306.g001
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organs refer to organs collected from animals born from sesame oil
exposed dams. Animals were housed and maintained according to
published European communities’ guidelines (86/609/CEE) and
all the performed experiments on animals were approved by the
experimental animal committee of the Paris Rive Gauche site
(Agreement A75-13-17, Centre National de la Recherche
Scientifique, Paris 7 University, Paris, France). A detailed protocol
of TCDD exposure and follow-up of the animals has been
published [19].
RNA Preparation and Microarray Analysis
Changes in global gene expression induced by TCDD were
analyzed in 5-day old testes and in 14-day old ovaries. In both
cases, 3 rats treated in utero by TCDD were compared to 3 rats
treated with sesame-oil vehicle. RNA extraction was performed
with the RNeasy Mini RNA extraction kit (Qiagen, Courtaboeuf
France).
Microarray analysis has been performed in the genomic and
microgenomic core facility profileXpert (Bron, France) as
described previously [20,21], using a high-density oligonucleotide
array (GeneChip Rat Genome 230 2.0 array, Affymetrix, Santa
Clara, CA, USA), and following Affymetrix protocol (http://www.
affymetrix.com). The arrays were read with a confocal laser
(Genechip scanner 3000, Affymetrix). Then CEL files were
generated using the Affymetrix GeneChip Command Console
(AGCC) software 3.0. The obtained data were normalized with
Affymetrix Expression Console software using MAS5 statistical
algorithm. Normalized data were compared and filtered using
Partek Genomic Suite software 6.5 (Partek Inc., St. Louis, MO,
US). Microarray data are available in the GEO database under
the number GSE32890.
Analysis of microarray data.
A principal component analysis (PCA) of the complete list of
genes present in the chip and two sample t-test were performed
between TCDD samples and control samples for ovaries and for
testes. Only genes showing a variation of at least 1.5-fold and a p-
value less than 0.05 were retained. Then, a gene was considered as
differentially expressed between groups only if the detected signal
was above the background for at least one of the compared groups.
David functional annotation clustering (http://david.abcc.ncifcrf.
gov/conversion.jsp) was performed to identify enrichment in
biological functions and pathways. Promoter sequences (650pb) of
the regulated genes were extracted from Rat RGSC 3.4 assembly
Table 2. Sub-list of relevant genes TCDD-regulated in testes.
Gene Title Gene Symbol Fold Change
ADP-ribosyltransferase 2b Art2b 8.23
granzyme F Gzmf 4.40
aryl-hydrocarbon receptor repressor Ahrr 3.34
ficolin B Fcnb 2.00
peroxisomal biogenesis factor 11 alpha Pex11a 1.87
prostaglandin D2 synthase 2, hematopoietic Ptgds2/Hpgds 1.81
protein kinase (cAMP-dependent, catalytic) inhibitor beta Pkib 1.78
versican Vcan 1.68
fibroblast growth factor 16 Fgf16 1.62
prostaglandin reductase 2 Ptgr2 1.59
glycerol-3-phosphate acyltransferase, mitochondrial Gpam 1.58
spectrin repeat containing, nuclear envelope 1 Syne1 1.56
wingless-type MMTV integration site family, member 4 Wnt4 1.55
Cd44 molecule Cd44 1.51
tyrosine hydroxylase Th 1.51
platelet factor 4 Cxcl4/Pf4 1.32
chemokine (C-C motif) ligand 5 Ccl5/Rantes 21.50
stanniocalcin 1 Stc1 21.52
antisense paternally expressed gene 3 Apeg3 21.53
dipeptidylpeptidase 4 Dpp4 21.64
immunity-related GTPase family, M Irgm 21.73
growth hormone releasing hormone receptor Ghrhr 21.85
EGF-containing fibulin-like extracellular matrix protein 1 Efemp1 21.86
ATP-binding cassette, sub-family B (MDR/TAP), member 1A Abcb1a 21.89
cartilage acidic protein 1 Crtac1 22.05
fibroblast growth factor 13 Fgf13 23.15
SH2 domain protein 1A Sh2d1a 24.00
crystallin, gamma B Crygb 25.17
Genes were identified by the microarray procedure and their fold-change over control is indicated (gonad from untreated dams) (PF4/Cxcl4 was added in the list as a
relevant gene even though its fold change is ,1.5).
doi:10.1371/journal.pone.0040306.t002
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Table 3. Sub-list of characterized genes TCDD-regulated in ovaries.
Gene Title Gene Symbol Fold Change
aryl-hydrocarbon receptor repressor Ahrr 4.20
acyl-CoA thioesterase 1 Acot1 2.94
chemokine (C-C motif) ligand 5 Ccl5 2.50
Zinc finger protein 212 Zfp212 2.42
prolylcarboxypeptidase (angiotensinase C) Prcp 2.42
leucine rich repeat and Ig domain containing 1 Lingo1 2.22
prostaglandin D2 synthase 2, hematopoietic Ptgds2/Hpgds 2.00
claudin 15 Cldn15 1.98
leucine rich repeat containing 4C Lrrc4c 1.95
ras-related C3 botulinum toxin substrate 2 Rac2 1.79
reprimo-like Rprml 1.78
TBC1 domain family, member 10C Tbc1d10c 1.76
RT1 class II, locus Ba RT1-Ba 1.73
histocompatibility 2, class II antigen E alpha H2-Ea 1.73
granzyme K Gzmk 1.71
ADAM metallopeptidase domain 10 Adam10 1.70
carbonic anhydrase 5b, mitochondrial Car5b 1.69
complement component 1, q subcomponent, beta polypeptide C1qb 1.69
cystatin F (leukocystatin) Cst7 1.69
chemokine (C-C motif) ligand 6 Ccl6 1.67
C1q and tumor necrosis factor related protein 3 C1qtnf3 1.66
cytochrome P450, family 1, subfamily b, polypeptide 1 Cyp1b1 1.63
HEAT repeat containing 6 Heatr6 1.60
S100 calcium-binding protein A4 S100a4 1.58
platelet factor 4 Pf4/Cxcl4 1.57
potassium inwardly rectifying channel, subfamily J, member 11 Kcnj11 1.52
aldo-keto reductase family 1, member C-like 1 Akr1cl1 1.51
leucine rich repeat containing 61 Lrrc61 21.51
isoleucyl-tRNA synthetase 2, mitochondrial Iars2 21.51
CAP-GLY domain containing linker protein 1 Clip1 21.51
amphiphysin Amph 21.52
ELMO/CED-12 domain containing 2 Elmod2 21.54
tripartite motif-containing 2 Trim2 21.54
zinc finger, DHHC-type containing 1 Zdhhc1 21.54
proline-rich transmembrane protein 1 Prrt1 21.55
cytoplasmic linker associated protein 1 Clasp1 21.55
parathyroid hormone receptor 1 Pthr1 21.55
mutY homolog (E. coli) Mutyh 21.56
pinin, desmosome associated protein Pnn 21.58
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 Uap1l1 21.61
cholecystokinin Cck 21.61
sodium channel, voltage-gated, type VII, alpha Scn7a 21.61
phosphatidylinositol 4-kinase type 2 beta Pi4k2b 21.61
apoptotic chromatin condensation inducer 1 Acin1 21.62
potassium channel tetramerisation domain containing 13 Kctd13 21.64
neuronal pentraxin 1 Nptx1 21.64
mitogen-activated protein kinase 11 Mapk11 21.68
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 Abcc5 21.70
purinergic receptor P2X, ligand-gated ion channel, 3 P2rx3 21.71
S100 calcium binding protein B S100b 21.72
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using BioMart, and firstly analyzed for pattern matching using
Common TFs from the Genomatix software package (Genomatix
software suite v2.5, Mu¨nchen, Germany). Briefly, the sequences
were scanned for matches to Transcription Factor binding sites
and only matrices displaying an enrichment p-value ,0.05 were
considered enriched in the promoters of interest compared to the
rest of the vertebrate promoter sequences.
Reverse Transcription and Real-time RT-PCR
Reverse transcription was carried out with 250 ng of total RNA
recovered from testes (of 5, 28, 40, 67, 145 days of age), ovaries (of
3, 6, 10, 12, 14, 25 days of age), pituitaries (of females aged of 3, 6,
12, 14 days of age) or livers (of 5 and 28 days for males and 3 and 6
days for females), 400 ng oligo-dT primers (Qiagen) and
Superscript II reverse transcriptase (Invitrogen, France). Real-
time RT-PCR (QRT-PCR) was performed in a LightCycler 480
instrument (Roche Diagnostics, Mannheim, Germany) using the
LightCycler 480 SYBR Green I Master mix according to the
manufacturer’s protocol. Primers used are listed in table 1. They
were tested before use for specificity and efficacy. Amplification
conditions were as following: 10 min at 95uC followed by 40 cycles
of denaturation (10 sec at 95uC), annealing (10 sec at 60uC), and
extension (10 sec at 72uC) with single acquisition of fluorescence at
the end of each extension step. The specificity of PCR products
was confirmed by analysis of the melting curve and agarose gel
electrophoresis. All samples were run in quadriplicate reactions
(duplicate of two dilutions). Quantification of gene expression was
performed using the Relative Quantification Software (Roche
Table 3. Cont.
Gene Title Gene Symbol Fold Change
ubiquitin-like modifier activating enzyme 7 Uba7 21.73
Translocase of outer mitochondrial membrane 34 Tomm34 21.74
ATP-binding cassette, sub-family G (WHITE), member 1 Abcg1 21.76
family with sequence similarity 92, member A1 Fam92a1 21.78
solute carrier organic anion transporter family, member 1a4 Slco1a4 21.81
period homolog 3 (Drosophila) Per3 21.83
basic helix-loop-helix family, member e41 Bhlhe41 21.85
Fc receptor-like S, scavenger receptor Fcrls 21.97
phosphodiesterase 10A Pde10a 21.98
spastic paraplegia 3A homolog (human) Spg3a 22.14
nucleoporin 62 C-terminal like Nup62cl 22.47
Genes were identified by the microarray procedure and their fold-change over control is indicated (gonad from untreated dams).
doi:10.1371/journal.pone.0040306.t003
Table 4. David functional analysis.
ovarian genes cluster
enrichment
scores p-value Examples of genes
up-regulated (34 identified; 4 unknwon) immune response, positive regulation of cell
differentiation and developmental processes
2.43 4.7.1024 Ccl5, Adam10
positive regulation of response to stimulus 1.93 5.1024 Ccl5, Ccl6, Adam10
chemotaxis and chemokine activity 1.7 3.3.1024 Ccl5, Ccl6, Pf4
response to steroid hormone stimulus and organic
substance
1.56 1.2.1022 Adam10, Ccl5, Cyp1b1
down-regulated (56 identified; 19
unknown)
behavior 1.4 2.7.1022 S100a4, Amph, Cck
Summary of the analysis using the list of genes regulated by TCDD in ovary.
doi:10.1371/journal.pone.0040306.t004
Table 5. Expression levels of classical genes targeted by
TCDD.
ovary Testis
control TCDD
Fold-
Change control TCDD
Fold-
change
Ahrr 18 79 4.2* 14 48 3.34*
Cyp1a1 nd nd nd nd nd nd
Cyp1a2 nd nd nd nd nd nd
Cyp1b1 1419 2300 1.63* 1079 1315 1.22
Cyp2s1 66 55 0.83 65 54 0.83
Nqo1 350 470 1.34* 303 444 1.46
Gsta1 13200 12800 0.96 7705 7652 0.99
Aldh3a1 nd nd nd nd nd nd
Ugt1a6 210 273 1.3 381 436 1.14
Data were obtained using ovaries of 14 days of age and testes of 5 days of age.
*p,0.05; nd, not detectable.
doi:10.1371/journal.pone.0040306.t005
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Figure 2. Ahrr, Cyp1a1, Cyp1b1 and Nqo1 gene expression levels in testes and ovaries of rats exposed in utero to TCDD. Testes were
recovered from males aged from 5 to 145 days (A) and ovaries were recovered from females aged from 3 to 25 days (B). Testes samples did not have
detectable Cyp1a1 levels (A). Levels were normalized using Hprt. Values are the mean 6 SEM of n = 4 to 6 animals (n = 2 for 3- and 25-day control
ovaries). *p,0.05 versus its time-matched control. (dpn), days postnatal.
doi:10.1371/journal.pone.0040306.g002
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Diagnostics), and data were expressed as a ratio of target gene to
the reference gene hypoxanthine phosphoribosyltransferase,
HPRT. Statistical analyses were done using Statview 5.0 software
package (SAS Institute Inc. Cary, NC 27513). Comparisons
between treatments were made by one-way analysis of variance
(ANOVA) followed by the post hoc Fisher PLSD test for multiple
comparisons. A p value of less than 0.05 was considered significant.
Results
Reproductive Parameters of the F1 Offspring
A follow-up of the female offspring including body weight,
fertility assessment and measurement of mRNA levels of some key
genes involved in the endocrine function of the ovary during
prepubertal period is provided (Supporting Information S1).
Except for body weight, no significant differences were obtained.
Regarding the male offspring exposed in utero to TCDD,
testicular and epididymal weight did not change. Testis histology
was grossly normal so were testosterone levels throughout
development. A precise description was provided previously [19].
Global Analysis of Testes and Ovaries Transcriptomic
Data
The total amount of genes expressed in ovaries and testes was
approximately of 65% of the rat genome, indicating that an
average of 20,000 genes is expressed in the gonads. PCA analysis
did not allow segregating genes between treated-testes and control
testes, or between treated-ovaries and control ovaries. It indicated
that the sample to sample variation within the group (male or
female) was bigger than the variation due to the treatment (not
shown). A two sample t-test was next performed and a list of 113
and 56 differentially expressed genes showing a variation of 1.5-
fold and a p-value less than 0.05 came out in ovary and testis,
respectively. Of the 113 genes responding to TCDD in ovaries, 38
were up-regulated and 75 down-regulated. In testes, 27 were up-
regulated and 29 down-regulated (Fig. 1). About, half of them are
not fully characterized and are identified by their Affymetrix
probeset ID. Some of them are transcribed locus or expressed
sequence tags (ESTs). A sub-list of characterized genes differen-
tially expressed in response to TCDD, in testes and in ovaries is
given in Tables 2 and 3, respectively. We also identified a total of 7
genes common to testes and ovaries if cross-comparing the list of
regulated genes that exhibited at least a 1.5 fold change over its
respective control. There were Ahr repressor (Ahrr), prostaglandin
D2 synthase 2, hematopoietic (Ptgds2/Hpgds), the chemokines
Rantes/Ccl5 and Pf4/Cxcl4, and 3 uncharacterized genes which
were not further studied (Fig.1, Tables 2, 3).
David functional annotation clustering indicated one cluster
with enrichment score of 1.61 and a p-value of 4.9.1023 using the
total list of testis genes. It corresponded to immune and defense
response with 6 transcripts including Ccl5 and Pf4. No cluster
came out if only the list of the up or down-regulated genes was
considered. Using the list of the up-regulated genes in the ovary, 4
clusters came out with enrichment score comprised between 1.56
and 2.43 and corresponding to immune response, positive
regulation of response to stimulus, chemotaxis and chemokine
activity, and response to steroid hormone stimulus. In addition,
KEGG pathway pointed to the chemokine signaling pathway
associating Ccl5, Ccl6 and Pf4. A single cluster with an
enrichment score of 1.4 and corresponding to behavior came
out when uploading the list of down-regulated genes (Table 4).
Expression of Genes Belonging to the Classic Battery of
TCDD Target Genes
To extend microarray data, we first focused on Ahrr strongly
induced in both gonads, and other genes belonging to the TCDD-
inducible Ahr gene battery. The TCDD battery includes in
addition to Ahrr which acts as a dominant negative factor to
repress Ahr induced signalling pathways [22,23], four phase I
xenobiotic metabolizing enzymes, i.e., Cyp1b1, Cyp1a1, Cyp1a2,
and Cyp2s1, and four phase II xenobiotic metabolizing enzymes,
i.e., NADP(H) quinone oxidoreductase (Nqo1), glutathione
Figure 3. Ahrr, Cyp1a1, Cyp1b1 and Nqo1 gene expression
levels in pituitaries of rats exposed in utero to TCDD. Pituitaries
were recovered from females aged from 6 and 14 days of age. Levels
were normalized using Hprt. Values are the mean 6 SEM of n= 3 to 5
animals. * p,0.05 versus its time-matched control. (dpn), days postnatal.
doi:10.1371/journal.pone.0040306.g003
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transferase a1 (Gsta1), cytosolic aldehyde dehydrogenase-3 (Aldh-
3a1), and UDP glucuronosyltransferase 1a6 (Ugt1a6) (Table 5).
Three genes, Cyp1a1, Cyp1a2 and Aldh-3a1 were not found at
detectable levels in the gonads. Two genes appeared to be
constitutively expressed (Cyp2s1 and Gsta1) or weakly enhanced
(Nqo1 and Ugt1a6) after TCDD treatment. Cyp1b1 was
significantly up-regulated in ovaries (FC 1.63) but not in testes
(FC 1.22 with a p-value of 0.36). Finally, gene coding Ahrr was the
most up-regulated gene in both gonads of treated animals (FC 4.2
in ovaries and 3.34 in testes).
To validate and extend the microarray results, we analyzed the
expression of Ahrr and Cyp1b1 as well as Cyp1a1 and Nqo1 using
real-time PCR. This was done not only in ovaries at 14 days and in
testes at 5 days but also during a period of time extending from 3–
25 days in females and 5–145 days in males to cover critical
developmental steps in both gonads. Real-time PCR confirmed
the findings of the microarray in gonads (Fig. 2). For example in
testes, Ahrr was significantly enhanced at 5 days of age although
the fold-change was lower than the one observed using micro-
array. In addition, none of the metabolizing enzymes had their
gene expression levels altered after TCDD treatment (Fig. 2).
Noticeably, Cyp1a1 gene was not expressed in testis, either control
or TCDD-treated (not shown). Cyp1b1 and Nqo1 expression
levels increased as a function of age from 5 to 145 days (Fig. 2). In
contrast, neonate ovaries recovered from the same litters were
strongly responsive to TCDD exposure. Expression levels of Ahrr
were maximally up-regulated at 3 and 6 days. A significant
enhancement was still observed until 14 days, consistent with the
microarray data. No effect was observed in ovaries of 25 days. Of
note, Ahrr gene expression levels were almost undetectable in
control ovaries (Fig. 2). Cyp1a1, the hallmark of TCDD-inducible
Ahr gene [24], although not present in control ovaries was highly
induced in TCDD-treated ovaries of 3 to 10 days, peaking at 10
days. No expression was detected at 14 days consistent with the
microarray data (Table 2). Gene expression levels of Cyp1b1 and
Nqo1 were at detectable levels in control ovaries and roughly
constant from 3 to 25 days of age. Treated ovaries had enhanced
levels of Cyp1b1 and Nqo1 from 3 to 14 days, also in agreement
with the microarray data. No differences were observed at 25 days
(Fig. 2).
We also studied an additional endocrine organ, the pituitary,
and the liver as the primary detoxifying organ. Data synthesized
on Fig. 3, indicate a strong and significant enhancement of Ahrr,
Cyp1a1, Cyp1b1 and Nqo1 at 6 days of age in pituitary of TCDD-
treated animals. Although significant, induction was less pro-
nounced at 14 days of age (Fig. 3). As expected, RNA from both
male (5 days old) and female (6 days of age) liver showed increased
Ahrr and Nqo1 expression levels (data not shown) in treated
animals consistent with the induction in Cyp1a1 mRNA levels
reported previously [19].
Expression of Chemokines in Response to TCDD in
Gonads but also in Pituitary and Liver
Consistently with our previous data [19], we observed down-
regulation of Ccl5 and upregulation of Pf4/Cxcl4 in the testes
of 5-day old rats of TCDD-treated dams (Table 2). In females,
microarray studies indicated that both Ccl5 and Pf4/Cxcl4 were
significantly up regulated 2.5- and 1.57-fold, respectively
(Table 3). In addition, KEGG pathway pointed to the
chemokine signaling pathway associating Ccl5, Ccl6 and Pf4/
Cxcl4, in ovary and one enriched cluster comprised of Ccl5 and
Pf4/Cxcl4 in testis. To define if chemokines could be targeted
by TCDD in other organs, real-time PCR was performed with
RNA from pituitary and liver. We found that pituitaries
recovered from 14-day-old female rats from TCDD-treated
dams had increased Ccl5 (3.26 fold-change, n = 4; p,0.05) and
Figure 4. Gzmf, Art2b, Hpgds and Fgf13 gene expression levels in testes of rats exposed in utero to TCDD. Testes were recovered from
males of 5, 28 and 67 days of age. Levels were normalized using Hprt. Values are the mean 6 SEM of n = 4 animals. *p,0.05 versus its time-matched
control. (dpn), days postnatal.
doi:10.1371/journal.pone.0040306.g004
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Pf4/Cxcl4 (1.81 fold-change, n= 4; p,0.05) versus time-
matched controls. Ccl5 but not Pf4/Cxcl4 was also up-regulated
(2.12 fold-change, n= 4; p,0.05) in the liver recovered from
28-day old male rats (data not shown).
TCDD-regulated Genes in Testis and Comparison with
Two Endocrine Organs (Ovary and Pituitary) and Liver
Microarray data were further exploited by real-time PCR to
analyse the testis response to TCDD exposure. Genes selected
included Art2b, Gzmf/Nrkp7, and Fgf13 because they were
among the most regulated genes in testis, and Ptgds2/Hpgds
because it was regulated in both sex gonads (Table 2). We
observed up-regulation of Gzmf/Nrkp7, Art2b, Ptgds2/Hpgds
and down-regulation of Fgf13 (p,0.05) at 5 but not at 28 or 67
days (Fig. 4).
In ovaries, Ptgds2/Hpgds was present at all ages investigated
from 3 to 25 days. Enhanced expression levels of Ptgds2/Hpgds
were observed in the ovaries of rats from TCDD-treated dams
at 6, 12 and 14 days but not at 3 and 25 days of age (Fig. 5).
Fgf13 was present in neonate ovaries (3 and 6 days of age) but
its expression levels did not change in treated ovaries (Fig. 5).
Art2b and Gzmf/Nrkp7 were neither expressed in the ovary at
6, 10 and 14 days of age, nor induced in the ovaries of rats
from TCDD-treated dams at these age-time points (not shown).
In pituitaries, Gzmf/Nrkp7 and Art2b were present at 3 and
12 days of age and organs from treated animals exhibited levels
higher than 2-fold over control levels (Fig. 6). Fgf13 was also
present in pituitaries collected from 3 and 12 days old animals,
and its expression levels were significantly decreased (a 20%
decrease) in treated organs (Fig. 6). Ptgds2/Hpgds was expressed
in pituitary but not TCDD-regulated (Fig. 6). Finally, real-time
PCR using liver from 3 and 6 day-old animals revealed
transcripts for Gzmf/Nrkp7, Art2b and Ptgds2/Hpgds but not
Fgf13, with TCDD up-regulation of Gzmf/Nrkp7 and Art2b
(p,0.05) at 3 but not at 6 days of age. Ptgds2/Hpgds was not
targeted (Fig. 7). Table 6 recapitulates data.
Identification of DNA Matrices, Potential Sites for
Transcription Factors
To find out whether certain transcriptional factor binding site(s)
were enriched in the TCDD-regulated genes identified in this
study, we selected 650bp promoter of each gene, and searched for
DNA matrices families using Genomatix promoter analysis. A
total of 25 promoter sequences for testes regulated genes and 54
promoter sequences for ovaries regulated genes could be
processed. We observed that the DNA matrices family ETSF
was consistently identified in the promoters of all 25 TCDD
regulated genes in testes (Table 7) and the 54 regulated in ovaries
(Table 8). We also identified 10 other overrepresented matrices
families’ specific to either testes or ovaries (Table 8) which may
account for the gender differences that we detected in this study.
Discussion
The objective of our project was to determine the impact of an
in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
on reproductive function of male and female offspring in the rat
with a special emphasis on the immature period, in conditions in
which reproductive parameters are grossly normal both in males
[19] and in females (this study). To this end, animals were exposed
during gestation to low doses to avoid collateral toxic effects. We
also considered the TCDD half-life of 3 weeks in rodents, and
conclusions published [25] indicating that the majority of
occurrences of TCDD in offspring of dosed dams arise from
lactational transfer of TCDD. In addition, given the unexpected
microarray results highlighting gender difference responses; we
developed a real time PCR approach on gonads at various
developmental periods of interest. On the one hand, this approach
permitted to extend our study on male and female gonad
development following an in utero exposure to TCDD. On the
other hand, this approach allowed comparing common stages in
both sexes (specifically, 5 and 28 days in testes, and 6 and 25 days
in ovaries).
The microarray technology is a powerful method allowing full
gene analyses of different samples. It is especially fruitful when
scarce differences are expected. In the present study, less than 1%
of the expressed genes in gonads were found to be altered
following embryonic TCDD exposure. Specifically, we identified a
total of 113 genes in ovaries and 56 genes in testes differentially
regulated by the treatment over the 20,000 genes found expressed
in the ovary and testis, respectively. The low number of regulated
genes found in testis versus the ovary probably suggested that
TCDD may have less deleterious effects in testes than in ovaries.
This could result from the lack of response of the TCDD battery of
detoxifying genes in testis by comparison with the neonate ovary.
Indeed, TCDD only induced gene expression of Ahrr in neonate
Figure 5. Hpgds and Fgf13 gene expression levels in ovaries of
rats exposed in utero to TCDD. Ovaries were recovered from
females of 3 to 25 days of age. Levels were normalized using Hprt.
Values are the mean 6 SEM of of n= 4 to 6 animals (n = 2 for 3- and 25-
day control ovaries). *p,0.05 versus its time-matched control. (dpn),
days postnatal.
doi:10.1371/journal.pone.0040306.g005
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testes while in ovaries, Cyp1a1, Cyp1b1, and Nqo1 exhibited a
very high up-regulation in addition to Ahrr. Ahrr functions as a
naturally occurring dominant-negative factor [22,23]. Hence,
Ahrr is an important determinant of tissue specific responsiveness
to TCDD, and strong evidences have been reported on an inverse
relationship between Ahrr expression and sensitivity to induction
of xenobiotic-metabolizing enzymes caused by TCDD. This is
coherent with elevated constitutive levels of Ahrr in testis [26,27].
The data presented herein i.e., high expression of Ahrr and no
detectable Cyp1a1, Cyp1b1 and Nqo1 induction in testis are in
keeping with these observations.
Nonetheless, the presence of Ahrr and its up-regulation in
TCDD treated testes indicate that the Ahr canonical pathway is
active in testis even though the role played by Ahr in testis is
misunderstood. Impairment of the urogenital sinus is the major
phenotype in Ahr2/2 male mice [8,28]. Testis alteration was also
reported in aged Ahr2/2 mice with reduced testosterone
production and sperm numbers [29]. It is of interest that enzymes
of the TCDD battery of inducible genes expressed in testis
including Cyp1b1 and Nqo1 had their expression levels increasing
as a function of time, from infancy to adulthood. It may suggest
that these enzymes, which are confined to Leydig cells in testis
[30,31], exert a physiological role during development in relation
with the endocrine status of the animal.
Our data also illustrated that in addition to liver, which is a
primary detoxification organ, endocrine organs such as ovary and
pituitary displayed an up-regulation of the expression of genes
coding enzymes of the detoxifying machinery. For example, in
both ovary and pituitary there was an induction of Cyp1a1 which
is the hallmark of TCDD exposure [24]. Nonetheless, Cyp1a1
induction was no longer observed at 12 days of age in the ovary
while still detected at 14 days in pituitaries (and 25 days, not
shown) and 28 days in livers [19], illustrating organ specificity in
the timing of the response. Indeed, the other detoxifying genes
studied in ovary, i.e., Ahrr, Cyp1b1 and Nqo1 were still enhanced
at 12 and 14 days of age. Together, these data are in keeping with
previous studies demonstrating enhanced Ahrr and Cyp1a1 in the
pituitaries of male rats exposed to an acute-dose of TCDD at the
adult age [32]. Regarding the ovary, evidences have been brought
indicating enhanced Cyp1a1 in response to dioxin [33]. However,
to our knowledge, this is the first report illustrating the TCDD-
induction of Ahrr in ovary.
Present data extend our previous study reporting alteration of
chemokines in the testes of TCDD-treated rats, with up-regulation
of Cxcl4 and down-regulation of Ccl5 [19], and other studies
pointing out that various chemokines were targeted by TCDD
exposure including Ccl5 in a model of endometriosis [34], Ccl1
[35], Ccl2 [36]. In this study, the chemokine pathway associating
Ccl5, Pf4/Cxcl4 and Ccl6 was induced in TCDD-treated ovaries.
Therefore, in addition to growth factors and cytokines [37],
chemokines might be added to the list of the TCDD-targeted
genes, extending the notion that TCDD interacts with the
inflammatory pathways.
Our results also evidenced a sex specific response of gonads to
the TCDD exposure with Fgf13, Art2b, and Gzmf regulated in
testes but not in ovaries, and, a gonad gene expression signature
with Ptgds2/Hpgds. Indeed, this study demonstrated that Ptgds2/
Hpgds, although expressed in various tissues, was only regulated
by TCDD in the gonads. Interestingly, none of these genes, and
Ccl5 and Pf4/Cxcl4 exhibited-XRE elements in the 2,0000 bp
Figure 6. Gzmf, Art2b, Hpgds and Fgf13 gene expression levels in pituitaries of rats exposed in utero to TCDD. Pituitaries were
recovered from females of 3 to 12 days of age. Levels were normalized using Hprt. Values are the mean 6 SEM of n= 4 animals. *p,0.05 versus its
time-matched control. (dpn), days postnatal.
doi:10.1371/journal.pone.0040306.g006
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upstream of the transcription sites, in rats (not shown). This
situation contrasted with the mouse orthologs of Art2b, Fgf13,
Ptgds2/Hpgds and Ccl5 having XRE elements in the 2,000 bp
upstream of the transcription sites (http://drgap.nies.go.jp/pub/
page/element). Nonetheless, these genes may be direct targets if
considering that only 1/3 of the gene expression responses elicited
by TCDD involves direct AhR binding to a XRE [11]. It may also
indicate that the TCDD-induced enhancement of these genes is
secondary to a primary event, which remains to be defined. It may
well be the case for Ptgds2/Hpgds because its induction in ovary
was not immediate and could not be detected at 3 days of age, an
age at which all the detoxifying genes have been shown to be
deregulated. We cannot ascertain that this situation is female-
specific because we did not recover males younger than 5 days of
age.
Ptgds2/Hpgds is a cytosolic protein responsible for the
biosynthesis of prostaglandin D2 (PGD2) in immune and
inflammatory cells, being widely distributed in antigen presenting
cells [38]. Interestingly, very recent data have brought new insight
into involvement of Ptgds2/Hpgds in differentiation and function
of gonads [39,40]. Ptgds2/Hpgds is expressed in the early
embryonic gonad in both sexes and participates to the initial
nuclear translocation of the Sox9 protein triggering Sertoli cell
differentiation in males [40]. It is also expressed in the adult ovary
where it indirectly participates to the regulation of progesterone
secretion [39]. Therefore, more studies need to be done regarding
to Ptgds2/Hpgds because of the stimulatory effect of PGD2 on
steroidogenesis regulation [39].
The 3 other genes, Fgf13, and Gzmf and Art2b, were among
the most differentially expressed genes in testis, in response to
TCDD. Fgf13 (also called Fgf homologous factor 2) was first
shown to be expressed in human fetal and adult brain and in
adult kidney [41]. Fibroblast Growth Factors (FGFs) form a large
family of conserved signaling proteins with essential develop-
mental functions in organ patterning and morphogenesis. Fgf13
belongs to the intracrine FGF family indicating that it is not
secreted and that it functions in an FGF receptor-independent
manner [42]. In fetal mice, Fgf13 expression was detected within
the mesonephros of both sexes at 12.5 embryonic day, and
restricted to testis by embryonic day 13.5 [43,44]. In the present
study, Fgf13 showed high inhibition in testis microarray and data
were validated by real time PCR with gene expression levels
halved in testis from TCDD-treated rats. Interestingly, its
expression was not regulated in ovaries while down- regulated
in pituitary; it may suggest that Fgf13 is under the regulation
of transcription factors commonly expressed in testis and
pituitary.
There is little information regarding Gzmf and Art2b and their
possible regulation by TCDD. Granzyme genes are serine
proteinases previously shown to be implicated in tissue remodel-
ling in the placenta and in the testis [45,46]. Art2b is an ADP-
ribosyl transferase gene, and 5 Arts have been described in the
mammalian genome. ADP ribosylation is a reversible post-
translational modification that can be used as a mechanism to
regulate endogenous functions [47]. The full significance of the
alteration of these genes in the testis and pituitary, but not in the
ovary recovered from siblings’ warrants further investigation.
Interestingly, through cross-comparison between the lists of DNA
matrices present in the proximal promoters of 25 genes in testes
and 54 genes in ovaries, all regulated by TCDD, we extracted
potential families of transcription factors allowing regulation by
TCDD in testis and/or ovary. However, the importance of these
findings remains to be determined.
Overall, our results evidenced that male and female gonads
responded differently to TCDD exposure showing, for example,
the induction of the canonic battery of genes coding enzymes of
the detoxifying machinery in ovaries but not in testes. We
illustrated that inflammatory pathway is one of the pathways
targeted by TCDD in gonads. Finally, we identified several new
genes targeted by TCDD, including Fgf13 in testis and one gene,
Ptgds2/Hpgds targeted in testis and ovary.
Figure 7. Gzmf, Art2b, and Hpgds gene expression levels in
livers of rats exposed in utero to TCDD. Livers were recovered
from females of 3 and 6 days of age. Levels were normalized using Hprt.
Values are the mean 6 SEM of n = 3 to 5 animals. *p,0.05 versus its
time-matched control. (dpn), days postnatal.
doi:10.1371/journal.pone.0040306.g007
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Table 6. Summary of the effects on Art2b, Fgf13, Gzmf and Ptgds2/Hpgds following TCDD exposure.
Testis Ovary Pituitary Liver
Ptgds2/
Hpgds
up-regulated at 5 but not
at 28 and 67 days of age
up-regulated at 6, 12 and
14 but not at 3 or 25 days
of age
expressed but not regulated
at 3 and 12 days of age
expressed but not regulated at 3
and 6 days of age
Fgf13 down-regulated at 5 but not
at 28 and 67 days of age
expressed but not regulated
from 3 to 25 days of age)
down-regulated at 3 and
12 days of age
not detected at 3 and 6 days of age
Gzmf up-regulated at 5 but not
at 28 and 67 days of age
not detected up-regulated at 3 and 12 days
of age
up-regulated at 3 but not at 6 days
of age
Art2b up-regulated at 5 but not
at 28 and 67 days of age
not detected up-regulated at 3 and 12 days
of age
up-regulated at 3 but not at 6 days
of age
doi:10.1371/journal.pone.0040306.t006
Table 7. List of Matrices Family overrepresented in the promoter sequences of the TCDD regulated genes in testes.
DNA Matrices Family Transcription factors p-value #sequences
V$ETSF Ehf, Elf1,Elf2, Elf3,Elf4, Elf5,Elk1, Elk3,Elk4,
Erf, Erg, Ets1, Ets2, Etv1,Etv2, Etv3,Etv4,
Etv5,Etv6, Fev,Fli1, Gabpa,Gabpb1, Gabpb1l,
Gabpb2, Sfpi1, Spdef, Spib,Spic
0.0127746 25
V$GCMF Gcm1, Gcm2 0.0072138 22
V$MYT1 Myt1, Myt1l,St18 0.0355996 22
V$CDXF Cdx1, Cdx2,Cdx4 0.00668855 21
V$SF1F Nr5a1, Nr5a2 0.00610062 16
V$RREB Rreb1 0.0090441 15
V$GRHL Grhl1, Grhl3 0.0176176 14
V$INSM Insm1 0.0473584 13
V$LTFM Ltf 0.00939393 12
V$NBRE Nr4a1, Nr4a2,Nr4a3 0.0365125 10
V$PAX9 Pax9 0.0173214 8
doi:10.1371/journal.pone.0040306.t007
Table 8. List of Matrices Family overrepresented in the promoter sequences of the TCDD regulated genes in ovaries.
DNA Matrices Family Transcription factors p-value #sequences
V$ETSF Ehf, Elf1,Elf2, Elf3,Elf4, Elf5,Elk1, Elk3,Elk4, Erf,
Erg Ets1, Ets2, Etv1,Etv2, Etv3,Etv4, Etv5,Etv6, Fev,
Fli1, Gabpa,Gabpb1, Gabpb1l, Gabpb2, Sfpi1,Spdef,
Spib,Spic
0.00212351 54
V$SP1F Cdca7l, Eapp,Klf10, Klf11,Klf5, Sp1,Sp2, Sp3,Sp4, Sp5,Sp6,
Sp7,Sp8
0.000099594 46
V$MYBL Myb, Mybl1,Mybl2 0.044378 46
V$IRFF Irf1, Irf2,Irf3, Irf4,Irf5, Irf6,Irf7, Irf8,Irf9, Rnf31 0.0422676 44
V$ZF02 Zbtb7a, Zbtb7b,Zfp148, Zfp202, Zfp219,Zfp281 0.0076816 41
V$EGRF Egr1, Egr2,Egr3, Egr4,Wt1 0.0218414 38
V$MAZF Maz, Zfp278 0.013593 33
V$CTCF Ctcf, Ctcfl,LOC100360757 0.0329843 33
V$PAX2 Pax2 0.0270729 27
V$ZF10 0.0137818 23
V$BTBF Zbtb33 0.0416754 14
doi:10.1371/journal.pone.0040306.t008
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Supporting Information
Supporting Information S1 Reproductive parameters of
the female progeny exposed in utero to TCDD. (a) F1
female progeny weight from 5 to14 postnatal days.
Values (g) are mean 6 SEM of () number of pups. TCDD-200 ng
females were significantly lighter than control females at 4, 7 and
10 postnatal days (* p,0.05). (b) F1 female fertility
assessment. Control females (7) and TCDD-200 ng females
(5) were mated continuously with males from 2 to 7 months of age.
A total of 5 litters was obtained for each female. Newborn pups
were sacrificed after 2 days to check viability. For each litter, the
mean number of days between beginning of mating and
parturition is indicated for the 7 control and 5 TCDD-treated
females. We also recorded the mean number of pups of each sex
for the 7 control and 5 TCDD-treated females. (c) Expression
levels of key genes involved in endocrine function of the
ovary. No significant differences were observed between control
and TCDD-200 ng treated females assessed through a transcrip-
tomic analysis on 14 dpn ovaries. Values are the mean of the 3
samples analysed by microarray. (d) Real-time RT-PCR
measurement of Cyp19a1 and Star genes in ovaries
during prepubertal period. Values were normalized using
Hprt and are mean 6 SEM of () number of ovaries. No significant
differences were observed between control and TCDD- 200 ng
treated females assessed from 3 to 25 postnatal days (dpn).
(DOC)
Acknowledgments
We thank the profileXpert transcriptomic platform (Bron, France), and
Se´verine Croze and Nicolas Nazaret for helpful assistance in microarray
experiments.
Author Contributions
Conceived and designed the experiments: BLMB SM. Performed the
experiments: SM DR MI RW CD EM. Analyzed the data: SM BLMB.
Wrote the paper: BLMB SM HV JCT.
References
1. Poland A, Knutson JC (1982) 2,3,7,8-tetrachlorodibenzo-p-dioxin and related
halogenated aromatic hydrocarbons: examination of the mechanism of toxicity.
Annu Rev Pharmacol Toxicol 22: 517–554.
2. Diamanti-Kandarakis E, Bourguignon J, Giudice LC, Hauser R, Prins GS, et al.
(2009) Endocrine-disrupting chemicals: an Endocrine Society scientific state-
ment. Endocr Rev 30: 293–342.
3. Hotchkiss AK, Rider CV, Blystone CR, Wilson VS, Hartig PC, et al. (2008)
Fifteen years after "Wingspread"–environmental endocrine disrupters and
human and wildlife health: where we are today and where we need to go.
Toxicol Sci 105: 235–259.
4. Larsen JC (2006) Risk assessments of polychlorinated dibenzo- p-dioxins,
polychlorinated dibenzofurans, and dioxin-like polychlorinated biphenyls in
food. Mol Nutr Food Res 50: 885–896.
5. Mocarelli P, Gerthoux PM, Needham LL, Patterson DG, Limonta G, et al.
(2011) Perinatal exposure to low doses of dioxin can permanently impair human
semen quality. Environ Health Perspect 119: 713–718.
6. Bell DR, Clode S, Fan MQ, Fernandes A, Foster PM, et al. (2011) Interpretation
of studies on the developmental reproductive toxicology of 2,3,7,8-tetrachloro-
dibenzo-p-dioxin in male offspring. Food Chem Toxicol 48: 1439–1447.
7. Foster WG, Maharaj-Briceno S, Cyr DG (2010) Dioxin-induced changes in
epididymal sperm count and spermatogenesis. Environ Health Perspect 118:
458–464.
8. Ohsako S, Fukuzawa N, Ishimura R, Kawakami T, Wu Q, et al. (2010)
Comparative contribution of the aryl hydrocarbon receptor gene to perinatal
stage development and dioxin-induced toxicity between the urogenital complex
and testis in the mouse. Biol Reprod 82: 636–643.
9. Gray LE, Ostby JS (1995) In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
alters reproductive morphology and function in female rat offspring. Toxicol
Appl Pharmacol 133: 285–294.
10. Salisbury TB, Marcinkiewicz JL (2002) In utero and lactational exposure to
2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,4,7,8-pentachlorodibenzofuran re-
duces growth and disrupts reproductive parameters in female rats. Biol Reprod
66: 1621–1626.
11. Dere E, Lo R, Celius T, Matthews J, Zacharewski TR (2011) Integration of
genome-wide computation DRE search, AhR ChIP-chip and gene expression
analyses of TCDD-elicited responses in the mouse liver. BMC Genomics 12:
365.
12. Huang G, Elferink CJ (2012) A novel nonconsensus xenobiotic response element
capable of mediating aryl hydrocarbon receptor-dependent gene expression.
Mol Pharmacol 81: 338–347.
13. Kobayashi S, Okamoto H, Iwamoto T, Toyama Y, Tomatsu T, et al. (2008) A
role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid
arthritis. Rheumatology (Oxford) 47: 1317–1322.
14. Sutter TR, Guzman K, Dold KM, Greenlee WF (1991) Targets for dioxin:
genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science 254:
415–418.
15. Boutros PC, Bielefeld KA, Pohjanvirta R, Harper PA (2009) Dioxin-dependent
and dioxin-independent gene batteries: comparison of liver and kidney in AHR-
null mice. Toxicol Sci 112: 245–256.
16. de Kretser DM, Loveland KL, Meinhardt A, Simorangkir, Wreford N (1998)
Spermatogenesis. Hum Reprod 13 Suppl 1: 1–8.
17. Dohler KD, Wuttke W (1975) Changes with age in levels of serum
gonadotropins, prolactin and gonadal steroids in prepubertal male and female
rats. Endocrinology 97: 898–907.
18. Meijs-Roelofs HM, Uilenbroek JT, de Jong FH, Welschen R (1973) Plasma
oestradiol-17beta and its relationship to serum follicle-stimulating hormone in
immature female rats. J Endocrinol 59: 295–304.
19. Rebourcet D, Odet F, Verot A, Combe E, Meugnier E, et al. (2010) The effects
of an in utero exposure to 2,3,7,8-tetrachloro-dibenzo-p-dioxin on male
reproductive function: identification of Ccl5 as a potential marker. Int J Androl
33: 413–424.
20. Wierinckx A, Roche M, Raverot G, Legras-Lachuer C, Croze S, et al. (2011)
Integrated genomic profiling identifies loss of chromosome 11p impacting
transcriptomic activity in aggressive pituitary PRL tumors. Brain Pathol 21:
533–543.
21. Sabbah M, Prunier C, Ferrand N, Megalophonos V, Lambein K, et al. (2011)
CCN5, a novel transcriptional repressor of the transforming growth factor beta
signaling pathway. Mol Cell Biol 31: 1459–1469.
22. Abel J, Haarmann-Stemmann T (2010) An introduction to the molecular basics
of aryl hydrocarbon receptor biology. Biol Chem 391: 1235–1248.
23. Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y (1999) Identification of a novel
mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 13: 20–25.
24. Barouki R, Coumoul X, Fernandez-Salguero P. (2007) The aryl hydrocarbon
receptor, more than a xenobiotic-interacting protein. FEBS Lett 581: 3608–
3615.
25. Li X, Weber LW, Rozman KK (1995) Toxicokinetics of 2,3,7,8-tetrachlorodi-
benzo-p-dioxin in female Sprague-Dawley rats including placental and
lactational transfer to fetuses and neonates. Fundam Appl Toxicol 27: 70–76.
26. Hahn ME, Allan LL, Sherr DH (2009) Regulation of constitutive and inducible
AHR signaling: complex interactions involving the AHR repressor. Biochem
Pharmacol 77: 485–497.
27. Korkalainen M, Tuomisto J, Pohjanvirta R (2004) Primary structure and
inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon
receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain.
Biochem Biophys Res Commun 315: 123–131.
28. Lin TM, Ko K, Moore RW, Simanainen U, Oberley TD, et al. (2002) Effects of
aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-
tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle develop-
ment in C57BL/6 mice. Toxicol Sci 68: 479–487.
29. Baba T, Shima Y, Owaki A, Mimura J, Oshima M, et al. (2008) Disruption of
aryl hydrocarbon receptor (AhR) induces regression of the seminal vesicle in
aged male mice. Sex Dev 2: 1–11.
30. Ge RS, Dong Q, Sottas CM, Chen H, Zirkin BR, et al. (2005) Gene expression
in rat leydig cells during development from the progenitor to adult stage: a
cluster analysis. Biol Reprod 72: 1405–1415.
31. Zappa F, Ward T, Butler J, Pedrinis E, McGown A (2001) Overexpression of
NAD(P)H:quinone oxidoreductase 1 in human reproductive system. J Histochem
Cytochem 49: 1187–1188.
32. Huang P, Ceccatelli S, Hakansson H, Grandison L, Rannug A (2002)
Constitutive and TCDD-induced expression of Ah receptor-responsive genes
in the pituitary. Neurotoxicology 23: 783–793.
33. Valdez KE, Shi Z, Ting AY, Petroff BK (2009) Effect of chronic exposure to the
aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin in female
rats on ovarian gene expression. Reprod Toxicol 28: 32–37.
34. Yu J, Wang Y, Zhou WH, Wang L, He YY, et al. (2008) Combination of
estrogen and dioxin is involved in the pathogenesis of endometriosis by
promoting chemokine secretion and invasion of endometrial stromal cells. Hum
Reprod 23: 1614–1626.
35. N’Diaye M, Le Ferrec E, Lagadic-Gossmann D, Corre S, Gilot D, et al. (2006)
Aryl hydrocarbon receptor- and calcium-dependent induction of the chemokine
Transcriptomic TCDD Signature in Gonads
PLoS ONE | www.plosone.org 13 July 2012 | Volume 7 | Issue 7 | e40306
CCL1 by the environmental contaminant benzo[a]pyrene. J Biol Chem 281:
19906–19915.
36. Vogel CF, Nishimura N, Sciullo E, Wong P, Li W, et al. (2007) Modulation of
the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) in mice. Arch Biochem Biophys 461: 169–175.
37. Haarmann-Stemmann T, Bothe H, Abel J (2009) Growth factors, cytokines and
their receptors as downstream targets of arylhydrocarbon receptor (AhR)
signaling pathways. Biochem Pharmacol 77: 508–520.
38. Trivedi SG, Newson J, Rajakariar R, Jacques TS, Hannon R, et al. (2006)
Essential role for hematopoietic prostaglandin D2 synthase in the control of
delayed type hypersensitivity. Proc Natl Acad Sci U S A 103: 5179–5184.
39. Farhat A, Philibert P, Sultan C, Poulat F, Boizet-Bonhoure B (2011)
Hematopoietic-Prostaglandin D2 synthase through PGD2 production is
involved in the adult ovarian physiology. J Ovarian Res 4: 3.
40. Moniot B, Farhat A, Aritake K, Declosmenil F, Nef S, et al. (2011)
Hematopoietic prostaglandin D synthase (H-Pgds) is expressed in the early
embryonic gonad and participates to the initial nuclear translocation of the
SOX9 protein. Dev Dyn 240: 2335–2343.
41. Greene JM, Li YL, Yourey PA, Gruber J, Carter KC, et al. (1998) Identification
and characterization of a novel member of the fibroblast growth factor family.
Eur J Neurosci 10: 1911–1925.
42. Itoh N, Ornitz DM (2011) Fibroblast growth factors: from molecular evolution
to roles in development, metabolism and disease. J Biochem 149: 121–130.
43. Beverdam A, Koopman P (2006) Expression profiling of purified mouse gonadal
somatic cells during the critical time window of sex determination reveals novel
candidate genes for human sexual dysgenesis syndromes. Hum Mol Genet 15:
417–431.
44. Cory AT, Boyer A, Pilon N, Lussier JG, Silversides DW (2007) Presumptive pre-
Sertoli cells express genes involved in cell proliferation and cell signalling during
a critical window in early testis differentiation. Mol Reprod Dev 74: 1491–1504.
45. Hirst CE, Buzza MS, Sutton VR, Trapani JA, Loveland KL, et al. (2001)
Perforin-independent expression of granzyme B and proteinase inhibitor 9 in
human testis and placenta suggests a role for granzyme B-mediated proteolysis in
reproduction. Mol Hum Reprod 7: 1133–1142.
46. Sferruzzi-Perri AN, Macpherson AM, Roberts CT, Robertson SA (2009) Csf2
null mutation alters placental gene expression and trophoblast glycogen cell and
giant cell abundance in mice. Biol Reprod 81: 207–221.
47. Glowacki G, Braren R, Cetkovic-Cvrlje M, Leiter EH, Haag F, et al. (2001)
Structure, chromosomal localization, and expression of the gene for mouse ecto-
mono(ADP-ribosyl)transferase ART5. Gene 275: 267–277.
Transcriptomic TCDD Signature in Gonads
PLoS ONE | www.plosone.org 14 July 2012 | Volume 7 | Issue 7 | e40306
